What’s at Stake?

After twenty-four months of navigating unprecedented economic turbulence, our company is continuing unbated and moving forward in its plan of capitalizing on an improving economy, improving weather as spring is fast approaching, and a focus on understanding why now is the best time to make an investment in ourselves – and in our own health!

Many public policies supported us through the worst of the pandemic, enabling our company to be a leader in expanding our product line with a focus on the individual and how learning more about oneself can be transformational.   Our company has continued to expand its list of strategic partners proving that we have a solid footing to rapidly grow our business in 2022 and beyond. Economic resilience in both the US and Canada continues, and as business grows because of the recovery we will grow as well.

The last two years have tested all of us. I am continually impressed by the resilience, passion, and commitment I’ve seen from everyone who is part of our company. The challenges have been daunting but our focus—ensuring that our customers are treated with respect and provided with exceptional customer service in a timely manner — has never wavered.

In the coming months we will be announcing some amazing news that will spark not only great interest in understanding why we are so optimistic about our future, but how we can unleash the power of science and technology together, in pursuit of a journey to great health never imagined.

From everyone here at DNA Labs, thank you for your trust and confidence in us.  It is our privilege to serve you believing that ‘good health belongs to everyone’.


Michael S. Kerzner

Chairman of the Board & Chief Strategist